The effect of periodontal therapy on neopterin and vascular cell adhesion molecule-1 levels in chronic periodontitis patients with and without acute myocardial infarction: a casecontrol study
The presence of neopterin in gingival crevicular fluid (GCF) is a marker were included. GCF samples were analyzed at baseline and after 3 and 6 months, and the probing pocket depth (PD), clinical attachment level (CAL), bleeding on probing, gingival (GI) and plaque (PI) indices were recorded.
We determined neopterin and VCAM-1 levels (concentration and total amount) using enzyme-linked immunosorbent assay (ELISA). No significant differences were seen between the AMI+CP and CP groups for PI, GI, GCF levels of neopterin and VCAM-1 at baseline. Results: The number of teeth with 5 mm≤CAL<7 mm and CAL≥7 mm were significantly increased in the AMI+CP group at baseline. There were no significant differences between the AMI+CP and CP for PI, CAL, GCF volumes, and the AMI+CP group had the highest clinical improvement in the number of teeth with 5 mm≤CAL<7 mm at the sixth month. There were significant positive correlations between clinical periodontal inflammation and the presence of neopterin and VCAM-1 in GCF prior to and following periodontal treatment, and between the GCF volume and clinical parameters. Conclusions: Data suggest that the total amount and concentration of neopterin and VCAM-1 in GCF seemed to be closely associated with periodontal disease severity in CP patients with AMI.
Moreover, the results of our study demonstrate that the past periodontal status is potentially correlated between groups, with similar periodontal disease severity. Periodontitis and acute myocardial infarction (AMI) are two diseases that share common risk factors 12 . In recent years, literature has paid attention to positive correlation between periodontitis and coronary heart disease, acute coronary events, including AMI 4 . In these studies, periodontitis is defined by clinical examination or radiologic criteria 6, 25 . and no data are currently available about GCF N and VCAM-1 levels in AMI patients with chronic periodontitis (CP). Thus, in this study, we aimed at assessing whether GCF levels of CP patients with AMI have an alteration in GCF levels of N and VCAM-1. We also assessed whether these alterations might be related to 
Clinical procedures
The periodontal examination included the assessment of plaque index (PI) 27 , gingival index (GI) 16 , probing depth (PD), bleeding on probing 
Statistical analysis
We performed data analysis using the SPSS 
Results
In total, sixty subjects were enrolled. In this scope, forty CP patients with and without AMI were examined in the third and sixth months following the periodontal treatment. No significant differences were found among the three groups with regarding gender, education status, level of income, number of teeth, and serum N values at baseline ( Table 1 ). The AMI+CP group had higher serum VCAM-1 levels compared with the other two groups. There were no significant differences between the CP and AMI+CP groups concerning PI
AMI+CP CP
Number of teeth with n=20 n=20 p Data given as mean±SD; p value by two way ANOVA. Same superscripts indicate that there is no statistically significant difference (p≥0.05), different superscripts indicate that the difference is statistically significant (p˂0.001, p˂0.05) ;PI=Plaque Index; GI=Gingival Index; PD=Probing Depth; CAL=Clinical Attachment Level; BOP=Bleeding on Probing; SD=Standart Deviation. T0, theraphy initiation; T3, 3 months after T0; T6, 6 months after T0 and GI, which, in addition, were higher in both groups when compared with the healthy control group (Table   2 ). An analysis was carried out to investigate the relationship between periodontal disease severity and AMI using the number of teeth with a CAL degree of 5 mm or more (Table 3) . In AMI patients, there were significantly fewer individuals with mild periodontitis and significantly more individuals with severe (and moderate-to-severe) periodontitis compared with patients in the CP group. At the third and sixth months, there were no significant differences between CP and CP+AMI groups for PI and CAL (Table 4) . Within each group, all clinical parameters showed statistically significant decreases at the third and sixth months.
The AMI+CP group showed statistically significant decreases in the number of teeth with 5≤CAL<7 and CAL≥7 mm after the periodontal treatment (Table 5 ).
AMI+CP and CP groups showed significant decreases in total amounts and concentrations of N and VCAM-1 in the GCF during the post-treatment period (Figure 1 ). 
Groups

Table 6-Correlation between total amount concentration of N, VCAM-1 and clinical parameters (r)
The effect of periodontal therapy on neopterin and vascular cell adhesion molecule-1 levels in chronic periodontitis patients with and without acute myocardial infarction: a case-control study
2018;26:e20170199 7/11
N=Neopterin; VCAM-1=vascular cell adhesion molecule-1; T0, theraphy initiation; T3, 3 months after T0; T6, 6 months after T0. Numbers above the column show mean values and short bars show standart deviation. Significant changes compared between T0, T3 and T6 are indicated by*,**,***(p˂0.001) for AMI+CP and γ,γγ,γγγ (p˂0.001) for CP group. Different superscripts indicate statistically significant differences from baseline to 6 months between and within the groups The decreases in the AMI+CP group were greater than those in the CP group, and this difference approached statistical significance (p<0.001). During pre-and post-treatment periods, there were no statistically significant differences between the two groups regarding the concentration and total amount of N and VCAM-1. There were significant positive correlations between concentrations, the total amount of GCF N and VCAM-1 and the periodontal variables at the given time points in the AMI+CP and CP group (Table 6 ).
The concentration of VCAM-1 in GCF was negatively correlated with BOP in the AMI+CP group. Although it may be expected that patients with AMI might have worse GI and BOP scores, because of the high rate of anti-platelet drug administration in these patients, carrying out a periodontal examination within 24-48 h of the infarction, eliminated this issue. The levels of N and VCAM-1 were similar in patients with AMI and those with CP only. In light of these results, it can be noted that the past periodontal history was not significantly different between the groups, indicating similar periodontal disease awareness, extent and severity. This similarity existed in both CP patients and patients with AMI, and it appears to be a reflection of the host response to periodontitis that is reflected in both N and VCAM-1 levels of patients. Determination of crevicular fluid levels of markers related to AMI is important to explain the exact role of periodontitisassociated systemic inflammation in AMI.
In a previous study, to define a threshold for periodontitis at which the risk of AMI was greatest, we compared different cutoff levels of pathologic PDs between groups
28
. PD values≥4 mm were defined as
The effect of periodontal therapy on neopterin and vascular cell adhesion molecule-1 levels in chronic periodontitis patients with and without acute myocardial infarction: a case-control study and AMI, which was reported previously 6, 28 . In studies by Beck, et al. 3 (2001) and Arbes, et al. 1 (1999) to evaluate the extent of periodontal disease, the percentage of tooth sites with different CAL levels were investigated. In this study, the association between 
Conclusion
In accordance with the outcomes of this study,
we conclude that development of a protective model 
